Investigational Site Number : 1240004

Calgary, Alberta T3A 2N1

0 studies enrolling now · 2 studies all time

What they study most

Breast Cancer Metastatic, Dermatitis Atopic

Studies at this site

• Phase 2 Study of Amcenestrant (SAR439859) Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer — Stopped early
• Observational Evaluation of Atopic Dermatitis in Pediatric Patients — Running, not enrolling